What: Shares of Array BioPharma, a biopharmaceutical company that's focused on developing novel drugs to fight cancer, skyrocketed by 51% in January, based on data from S&P Capital IQ, after ...
November was yet another profitable month to be an investor in Array BioPharma (NASDAQ: ARRY). Shares of the cancer-focused clinical-stage biopharma gained more than 32% during the period, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results